DESIGN OF THE SILENT CEREBRAL INFARCT TRANSFUSION (SIT) TRIAL

BACKGROUND: Silent cerebral infarct (SCI) is the most common cause of serious neurological disease in sickle cell anemia (SCA), affecting approximately 22% of children. The goal of this trial is to determine whether blood transfusion therapy will reduce further neurological morbidity in children wit...

Full description

Saved in:
Bibliographic Details
Published in:Pediatr Hematol Oncol
Main Authors: Casella, James F., King, Allison A., Barton, Bruce, White, Desiree A., Noetzel, Michael J., Ichord, Rebecca N., Terrill, Cindy, Hirtz, Deborah, McKinstry, Robert C., Strouse, John J., Howard, Thomas H., Coates, Thomas D., Minniti, Caterina P, Campbell, Andrew D., Vendt, Bruce A., Lehmann, Harold, DeBaun, Michael R.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572477/
https://ncbi.nlm.nih.gov/pubmed/20201689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08880010903360367
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items